Objection to the renewal of GM maize MON 89034 authorization

by name voted on 17.12.2020

Summary

The European Parliament opposes the renewal of the market authorization for genetically modified maize MON 89034, citing scientific and democratic concerns.

9 17.12.2020

Other

health

environment

agri-foodstuffs

Key points

The European Parliament opposes the renewal of the market authorization for genetically modified maize MON 89034.
There are significant concerns that toxicity studies using isolated proteins do not accurately reflect the biological effects of toxins within actual plant tissue.
Potential risks to human health include increased allergenicity and unknown impacts on the intestinal microbiome.
Environmental risks involve continuous exposure for non-target organisms and the potential development of resistance in target pests.

Vote

PPE

S&D

Renew

ID

Verts/ALE

ECR

GUE/NGL

NI

Total

Documents (PDFs)

MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 (MON-89Ø34-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Genetically modified maize MON 89034 (MON-89Ø34-3)

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.